MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
GILD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Gilead Sciences (GILD) Ownership - Who owns Gilead Sciences?

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
333 Lakeside Drive
Phone
+1 650 574-3000
Employees
17000
Web
https://www.gilead.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
160.36B
P/E Ratio
17.57
Total Cash
7.64B
Projected Growth
2.14
Total Debt
22.17B
Revenue
29.74B
Risk (Beta)
0.04
Dividend Yield
0.02
Total Cash/Share
6.16
Total Debt/Equity
71.31
Revenue/Share
23.72 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
GILD
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for GILD
A.I. Advisor
published General Information

General Information

a developer of therapeutic products and treatments for life threatening diseases

Industry PharmaceuticalsMajor

Profile
Details
Industry
Biotechnology
Address
333 Lakeside Drive
Phone
+1 650 574-3000
Employees
17000
Web
https://www.gilead.com